Facebook Instagram X-twitter Linkedin

Dermorphin (5mg)

Table of Contents

  • Quickstart Highlights

Dermorphin (5mg) protocols center on this potent opioid peptide originally isolated from amphibian skin, studied for its strong affinity to μ-opioid receptors. It has been researched for its potential role in modulating pain perception and producing profound analgesic effects. This guide outlines a controlled subcutaneous administration approach for the 5 mg vial format.

  • Reconstitute: Add 2.0 mL bacteriostatic water → 2.5 mg/mL concentration
  • Typical range: 50–200 mcg per dose (subcutaneous, research context)
  • Easy measuring: At 2.5 mg/mL, 1 unit = 0.01 mL = 25 mcg on a U-100 insulin syringe
  • Storage: Lyophilized: store at −20 °C; after reconstitution, refrigerate at 2–8 °C and use within 2–4 weeks
  • Protocol Overview

Concise summary of the subcutaneous regimen.

  • Goal: Investigate effects on pain modulation via μ-opioid receptor activation
  • Schedule: Intermittent use due to potency and receptor sensitivity
  • Dose Range: 50–200 mcg per administration
  • Use Context: Primarily limited to controlled research settings
  • Dosing Protocol

Suggested approach for the 5 mg vial format.

  • Start: 50 mcg to assess sensitivity
  • Target: 100–200 mcg per administration
  • Frequency: As needed in research protocols (not daily continuous use)
  • Vial Duration: One 5 mg vial provides multiple doses depending on usage
  • Timing: Based on study design; spacing between doses is important
  • Mechanism of Action

Dermorphin is a heptapeptide that acts as a highly selective and potent agonist of μ-opioid receptors in the central nervous system. These receptors are responsible for regulating pain perception, reward pathways, and certain physiological responses.

Compared to traditional opioids, Dermorphin demonstrates exceptionally high receptor binding affinity and potency in preclinical models. Activation of μ-opioid receptors leads to inhibition of pain signal transmission and increased pain tolerance. Due to its strength, it is primarily studied in controlled environments rather than general use.

  • Potential Benefits & Side Effects

Observations based on preclinical and limited research data.

Potential Benefits:

  • Extremely potent analgesic effects
  • High receptor selectivity may allow targeted study of pain pathways
  • Useful in controlled research exploring opioid receptor mechanisms

Possible Side Effects:

  • High risk of respiratory depression at elevated doses
  • Sedation, dizziness, or nausea
  • Potential for dependence or tolerance with repeated exposure
  • Strictly investigational; not approved for general medical use